IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Italian Phase 1/2 biotech developing stem cell gene therapies for solid tumors.
Industry: Health Care
Latest Trade: $2.95 +0.04 (+1.2%)
First Day Return: -4.3%
Return from IPO: -74.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/10/2021 |
Offer Price | $11.50 |
Price Range $10.50 - $12.50 | |
Offer Shares (mm) | 3.1 |
Deal Size ($mm) | $36 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 12/15/2021 |
Offer Price | $11.50 |
Price Range $10.50 - $12.50 | |
Offer Shares (mm) | 3.1 |
Deal Size ($mm) | $36 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Roth Capital |
Maxim Group LLC |
Company Data | |
---|---|
Headquarters | Milan, Italy |
Founded | 2014 |
Employees | 4 |
Website www.genenta.com |